People
Oculis, announces the appointment of Pravin U. Dugel, M.D. as Chairman of its Scientific Advisory Board (SAB). Dr. Dugel is internationally recognized for his research in the field of ophthalmologic diseases and brings extensive clinical experience.
Thomson Reuters recently announced their list of the top 100 most diverse and inclusive organizations. In the top 50 of the list there are 10 biopharma and medical device companies. Let’s take a look.
The past few days has had a flurry of activity in the industry with leadership changes. Let’s take a look at some of those!
Merck and Co., like many large corporations, has a mandatory retirement age of 65 for its chief executive officer. Today the company announced its board of directors and rescinded the policy to allow its current chief executive officer, Kenneth C. Frazier, stay on beyond his 65th birthday in December 2019.
Viracta Therapeutics, Inc., a clinical-stage drug development company advancing innovative approaches to treat viral-associated cancers and other serious diseases, announced the formation of its inaugural Scientific Advisory Board.
Ovarian cancer is the fifth leading cause of cancer-related deaths in the United States. It is estimated that this year there will be more than 22,000 women in the U.S. diagnosed with the disease and about 14,000 disease-related deaths.
Abingworth today announced that Brian Gallagher, PhD, will join Abingworth as a Partner based in the company’s Boston office.
InflaRx N.V. announced today that Jens Holstein has been appointed as a new board member of InflaRx, serving as Non-Executive Director.
Kavya Kopparapu to be Named a 2018 Davidson Fellow
Rajiv Movva to be Named a 2018 Davidson Fellow
PRESS RELEASES